| Title |
Firstâline chemotherapy in lowârisk gestational trophoblastic neoplasia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, July 2012
|
| DOI | 10.1002/14651858.cd007102.pub3 |
| Pubmed ID | |
| Authors |
Alazzam M, Tidy J, Hancock BW, Osborne R, Lawrie TA, Alazzam, Mo'iad, Tidy, John, Hancock, Barry W, Osborne, Raymond, Lawrie, Theresa A |
| Abstract |
This is an update of a Cochrane review that was first published in Issue 1, 2009. Gestational trophoblastic neoplasia (GTN) is a rare but curable disease arising in the fetal chorion during pregnancy. Most women with low-risk GTN will be cured by evacuation of the uterus with or without single-agent chemotherapy. However, chemotherapy regimens vary between treatment centres worldwide and the comparable benefits and risks of these different regimens are unclear. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 1% |
| Unknown | 66 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 12 | 18% |
| Student > Master | 10 | 15% |
| Student > Postgraduate | 8 | 12% |
| Researcher | 7 | 10% |
| Lecturer | 4 | 6% |
| Other | 12 | 18% |
| Unknown | 14 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 36 | 54% |
| Nursing and Health Professions | 3 | 4% |
| Agricultural and Biological Sciences | 3 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Social Sciences | 2 | 3% |
| Other | 4 | 6% |
| Unknown | 17 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 September 2012.
All research outputs
#18,316,001
of 22,679,690 outputs
Outputs from Cochrane database of systematic reviews
#11,415
of 12,298 outputs
Outputs of similar age
#126,568
of 164,342 outputs
Outputs of similar age from Cochrane database of systematic reviews
#152
of 171 outputs
Altmetric has tracked 22,679,690 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,298 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 2nd percentile – i.e., 2% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,342 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 171 others from the same source and published within six weeks on either side of this one. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.